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Immune Activation by Bacterial DNA: Review
A New Genetic Code
David S. Pisetsky immunomodulatory properties, extracts were fraction-
ated to identify molecules that exhibited in vivo antitu-Medical Service
mor activity. These efforts led to the isolation of a mate-Durham VA Medical Center
rial called MY-1 that caused regression of transplantableand Division of Rheumatology, Allergy,
tumors in vivo without direct tumor cytotoxicity. Re-and Clinical Immunology
markably, MY-1 was composed almost entirely of DNADuke University Medical Center
and RNA. Furthermore, induction of tumor resistanceDurham, North Carolina 27705
was sensitive to DNase and not RNase, suggesting that
DNA, like other bacterial macromolecules, had activities
as a biological response modifier (Tokunaga et al., 1984;Introduction
Shimada et al., 1985; Mashiba et al., 1988).
As demonstrated in experiments both in vivo and inBacterial DNAdisplays all of the properties predicted for
vitro, tumor resistance induced by DNA resulted froma foreign antigen of exceptional activity. It is structurally
increased natural killer (NK) cell activity. In vitro, MY-1diverse. It bears sequences that differ among species.
stimulated production of interferon-a/b as well as inter-It is large and capable of receptor cross-linking. Despite
feron-g, with interferon-a/b shown to be the predomi-these properties and the obvious analogy to a foreign
nant mediator of NK cell enhancement (Yamamoto etprotein, bacterial DNA, like all DNA, was until recently
al., 1988). Furthermore, DNA from a variety of bacterial,viewed as immunologically uniform, bland, and essen-
but not mammalian, sources could stimulate the NKtially inert. Among foreign macromolecules, bacterial
response, suggesting that specific base sequences orDNA attracted little interest from immunologists and was
base modifications, rather than the DNA backbone, areregarded as generally irrelevant to the encounter be-
critical for activity (Yamamoto et al., 1992b).tween bacteria and host.
The importance of base sequence to interferon induc-The past few years have witnessed a remarkable
tion was established directly by experiments assessingtransformation in the conceptualization of DNA as an
the in vitro activity of synthetic oligonucleotides bearingantigen. Because of a series of provocative studies,
randomly selected DNA sequences from cDNA for M.culminating in the description of the role of the CpG
bovis proteins. These experiments demonstrated that
motifs in murine B cell activation, bacterial DNA has
45-mer oligonucleotides containing a 6 base motif cen-
gained notoriety as an immunological player. These
tered on an unmethylated CpG sequence caused the
studies demonstrate that DNA fulfills the capabilities
most potent induction of NK cell activity. Because of
predicted by its structure and, because of an unex-
two 59 purines and two 39 pyrimidines, these sequences
pected use of the genetic code, has powerful actions
can form palindromes. Synthetic oligonucleotides as
on the immune system. These actions include not only
well as the MY-1 extract had activity in human as well as
B cell activation, but stimulation of cytokines and induc-
murine systems, suggesting a generalized mammalian
tion of specific antibodies. These properties reflect
system for cytokine induction (Tokunaga et al., 1992;
structural microheterogeneity and result from immuno-
Yamamoto et al., 1992a; Yamamoto et al., 1994).
stimulatory sequences. These sequences center on un-
These experiments indicate that bacterial DNA differs
methylated CpG residues and are much more common sufficiently in structure from mammalian DNA so that it
in bacterial DNA than in mammalian DNA. can exert immunological actions. Studies on the molec-
The discovery of the immune potential of bacterial ular structure of DNA are consistent with this possibility.
DNA has broad implications both for the mechanisms Thus, bacterial and mammalian DNA differ in two impor-
of host defense and for the burgeoning use of DNA in the tant features: first, mammalian DNA shows a much lower
treatment of human disease. Several novel approaches, expression of CpG dinucleotides than predicted by ran-
including antisense therapy, gene therapy, and DNA im- dom base utilization (CpG suppression), whereas bacte-
munization, entail administration of free or “naked” DNA. rial DNA has the expected distribution; and, second,
These DNA constructs and oligonucleotides bear se- cytosine is commonly methylated in mammalian DNA,
quences that are foreign to the host and are therefore whereas this base is not methylated in bacterial DNA
capable of inducing immune responses. Since these (Bird, 1987; Hergersberg, 1991). As a result, the content
responses may confound the therapeutic use of DNA, of immunostimulatory motifs with an unmethylated CpG
there are practical as well as theoretical reasons for sequence is much greater in bacterial DNA than in mam-
unraveling the immunological activities of bacterial malian DNA.
DNA. In the induction of interferon-g by other bacterial
molecules, macrophage/monocytes play a central role
Induction of Interferon by Bacterial DNA through the elaboration of interleukin-12 (IL-12), a major
Although the demonstration of murine B lymphocyte stimulator of interferon production by T cells and NK
activation by CpG motifs galvanized interest in the im- cells. Bacterial DNA and oligonucleotides with immuno-
mune potential of bacterial DNA (Krieg et al., 1995), the stimulatory motifs appear to use a similar mechanism,
initial discoveries in this field came from studies on the since in vitro interferon induction requires adherent cells
induction of tumor resistance in mice by Mycobacterium and is associated with IL-12 secretion. Furthermore, in-
terferon production by murine spleen cells is blockedbovis BCG. To define components of this organism with
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series of structurally dissimilar ligands, including Ac-
LDL, dextran sulfate, chondroitin sulfate, and lipopoly-
saccharide, as well certain polynucleotides, including
poly dG. Despite its broad reactivity for polyanions, re-
ceptor interaction does not simply reflect charge, since
polynucleotides other than dG do not bind well (Pearson
et al., 1993; Krieger and Herz, 1994).
Together, these observations suggest how different
regions of a DNA molecule may contribute to inter-
feron-g induction. Thus, runs of dG, while themselves
unable to stimulate IL-12 production, may facilitate this
response by binding to the scavenger receptor and pro-
moting oligonucleotide entry into macrophages/mono-
cytes. Once inside these cells, immunostimulatory mo-
tifs could, by an as yet undefined mechanism, augment
IL-12 gene transcription. Although this model is con-
structed on the basis of extracellular DNA, the source
of immunomodulatory motifs could also be intracellular
(e.g., intracellular infection or phagocytized microorgan-
isms), in which case dG elements might be less im-
portant.Figure 1. The Structure of Quadriplex DNA
Formation of quadriplex DNA by dG sequence involves formation of
interstrand or intrastrand G–G base pairs in a parallel or antiparallel Effects of Bacterial DNA on B Cells
orientation. The figure illustrates the structure of DNA resulting from In addition to its ability to stimulate cytokines, bacterial
tetramolecular parallel quadriplexes. Quadriplex DNA maybe impor- DNA is a potent mitogen for murine B lymphocytes,
tant in immune activation by promoting DNA uptake by macro-
suggesting an important role for this molecule in trig-phages and directly stimulating B cells. Reproduced with per-
gering innate immunity. As shown originally in vitro, DNAmission.
from a variety of bacteria can induce proliferation and
antibody production by murine B cells under conditions
in which mammalian DNA is inactive. Mitogenicity does
by antibodies to IL-12 as well as tumor necrosis factor
not require T cells and is a property of DNA itself as
a, indicating that these monokines determine the action
shown by nuclease sensitivity. This activity occurs with
of either NK or T cells (Halpern et al., 1996).
both single-stranded (ss) and double-stranded (ds) DNA
While CpG motifs may be necessary for the stimula-
and does not require an extended polynucleotide chain,
tion of interferon, they may not be sufficient. As shown
since DNA fragments of <100 bases retain activity (Mes-
in in vitro experiments, the stimulatory capacity of an
sina et al., 1991, 1993).
immunostimulatory motif is dependent upon its context To define the sequences conferring mitogenicity,
within a larger DNA structure. Thus, the activity of the small oligonucleotides 8–20 bases in length were tested
palindrome AACGTT varies with the flanking bases in for their in vitro stimulatory activity. The results of this
30-mer oligonucleotides, since strings of 59 and 39 dG analysis were striking and elevated interest in this field
residues lead to dramatically enhanced induction of in- as no prior study had done before. Thus, the motifs
terferon compared with other flanking bases. Further- responsible for the B cell stimulation are virtually the
more, a 30-mer dG oligonucleotide, while itself inactive, same as those that elicit interferon production and show
can block expression of interferon induced by an active the basic structure 59 Pu-Pu-CpG-Pyr-Pyr (Krieg et al.,
palindrome flanked by dG residues (Kimura et al., 1994). 1995). Although this structure encompasses palin-
Runs of dG residues, because of their potential to form dromes, stimulatory oligonucleotides do not necessarily
unconventional base pairs, can assume conformational have to have exact base pair matches. Methylation sta-
states other than a double helix. In particular, poly- tus is critical, however, since treatment of bacterial DNA
nucleotides comprised of dG residues can form four- with DNA methylase abrogates in vitro mitogenic ac-
stranded DNA structures known as quadriplex DNA (Fig- tivity.
ure 1). Because of the presence of extended dG runs in Although sequences for B cell mitogenesis and inter-
chromosomal DNA, especially at telomeres, quadriplex feron induction are congruent, stimulation of murine B
DNA has been hypothesized to be an important element cells may also involve sequences other than CpG motifs.
in either chromosomal organization or gene regulation Thus, poly dG as well an 18 base oligonucleotide dG
(Williamson et al., 1989; Sen and Gilbert, 1991). compound can effectively induce in vitro B cell prolifera-
Although dG runs can form distinct DNA structures, tion (Pisetsky and Reich, 1993). This ability of dG runs
the role of these sequences in interferon production may to stimulate mitogenesis raises the possibility that DNA
reflect events on the outside as opposed to the inside can stimulate B cells by more than one mechanism,
of cells. Macrophages express a cell surface molecule, defined by CpG motifs on one hand and quadriplex DNA
termed the macrophage scavenger receptor, that was on the other. CpG oligonucleotides can also induce IL-6
originally defined on thebasis of its binding of acetylated production by murine B cells, although dG oligonucleo-
low density lipoprotein (Ac-LDL). This receptor is nota- tides have not yet been tested for this property (Klinman
et al., 1996; Yi et al., 1996).ble for its specificity since it can bind at high affinity a
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Figure 2. Immunomodulatory Effects of Bac-
terial DNA
Immune activation by CpG motifs in bacterial
DNA involves direct effects on B cells and
macrophages as well as downstream effects
of cytokines on T cells. In the stimulation of
B andT cells, bacterial DNA mayact synergis-
ticallywith other factors (not shown) to induce
observed activities such as antibody produc-
tion or cytokine expression.
The functional properties of bacterial DNA are remark- The mechanisms by which bacterial DNA activates B
cells and regulates expression of cytokines such as IL-6ably similar to those of endotoxin, suggesting that bac-
and IL-12 are unknown. These events do not appear toterial DNA may play an analogous role in host defense.
require protein phosphorylation or induction of a cal-Furthermore, bacterial DNA can function synergistically
cium flux, however (Krieg et al., 1995). Furthermore, al-with other activating signals and,for example,potentiate
though the polymeric nature of DNA should allow effec-stimulation of B cells by anti–immunoglobulin M (IgM) as
tive receptor cross-linking, bacterial DNA need not bewell as prime the Schwartzman reaction. These findings
of high molecular mass to act, however, since many ofsuggest that DNA and endotoxin may act in concert
its effects can be reproduced by short oligonucleotidesduring inflammatory responses and both serve an adju-
(Messina et al., 1993).vant function (Krieg et al., 1995; Cowdery et al., 1996).
The cellular trafficking of bacterial DNA has not beenAmong the mysteries of mammalian DNA structure
well defined, although DNA, either bacterial or mamma-has been the marked deficiency in CpG sequences. CpG
lian, appears to enter cells by bulk phase endocytosissuppression has been without a clear explanation, al-
or potocytosis (Akhtar and Juliano, 1992; Bennett, 1993;though methylation of these sites has usually been con-
Vlassov et al., 1994). In addition, many cell types expresssidered important for transcriptional regulation. In view
receptors on their surface that can bind DNA, althoughof the power of foreign DNA to trigger immunity, an
their role in DNA uptake has not yet been defined (Ben-immunological basis for CpG suppression has been pro-
nett et al., 1985; Yakubov et al., 1989; Hefeneider et al.,posed. According to this postulate, the host, by main-
1992). Once inside cells, bacterial DNA could inducetaining a difference between the sequence of bacterial
cellular effects by a number of mechanisms, includingand mammalian DNA, has an effective screen for the
binding a transcriptional regulator (perhaps by mimick-presence of infection irrespective of the nature of the
ing its mammalian DNA target in a promoter) or blockingorganism (Doerfler, 1991; Krieg et al., 1995). This expla-
its action; forming triple-stranded DNAto alter transcrip-
nation for CpG suppression presumes that DNA func-
tional activity; and binding to mRNA to block translation
tions as a major stimulus for innate immunity, although
of a key regulatory protein by an antisense mechanism.
at present the hierarchy of foreign molecules with this Although the activity of immunostimulatory motifs is
function is unknown. Figure 2 summarizes the actions sequence dependent, their action may not require highly
of bacterial DNA in normal immunity. specific interactions with either a protein or nucleic acid
target. An alternative possibility is that CpG motifs allow
Mechanism of Bacterial DNA Action entry of DNA into a cell compartment where it can medi-
The stimulation of immune responses by bacterial DNA ate its effects owing to its polyanionic structure. A num-
implies a fundamentally new paradigm for the regulation ber of polyanions, such as dextran sulfate and heparin,
of gene action. According to current models of gene have powerful immunological properties, some of which
expression, transcription is controlled by regulatory pro- are shared with bacterial DNA (Arnold et al., 1972; Vogt
teins that bind to specific promoter regions and affect et al., 1973; Smith et al., 1990). The CpG motifs may
transcription rates. The functional activity of these pro- allow bacterial DNA to exert such effects by providing
teins is determined by modifications such as phosphory- a high concentration of a charged structure in a relevant
lation, interaction with other proteins, or the binding of site.
a small molecule ligand. Whatever the basis for these In addition to foreign DNA, foreign RNA can stimulate
effects, it is the DNA that is regulated. In the emerging immune responses, and it is possible that they utilize
similar mechanisms. Thus, dsRNA derived from virusesmodel in immunology, however, DNA is the regulator.
Immunity
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or synthetic duplexes such as poly I:poly C are potent organisms. Whether the differences in the response to
these DNA reflect pathogenicity, sites of colonization,inducers of interferon-a/b (Field et al., 1967; Lampson
et al., 1967). These compounds have been considered or the presence of certain sequences is not known.
Since all bacterial DNA have CpG motifs, the epitopekey triggers in the host response to viral infection and
affect metabolism of cells in part through the activation bound by these antibodies is not this structure. Further-
more, the content of this motif, since it is widely presentof a protein kinase whose production is enhanced by
interferon. This kinase has been denoted the dsRNA- on bacterial DNA, cannot explain selective antigenicity.
It is of interest in this regard, therefore, that NHS candependent protein kinase as well as the P1/eIF-2 kinase
(Hovanessian, 1989; Manche et al., 1992). When acti- also bind DNA from BK polyomavirus, suggesting that
immune response to foreign DNA may occur in a varietyvated by dsRNA, this kinase can phosphorylate IkB,
leading to the activation of NF-kB. The activation of NF- of infections (Fredriksen et al., 1993).
As shown by the analysis of the response to ssDNAkB may be important in the regulation of interferon-b
gene expression (Taniguchi, 1989; Visvanathan and from M. lysodeikticus, the properties of antibodies in
NHS and SLE sera differ significantly. Thus, anti-DNAGoodbourn, 1989; Kumar et al., 1994).
Although dsRNA is the most effective activator of the in NHS are predominantly IgG2, while SLE sera display
IgG1 and IgG3 in addition to IgG2. Another differencekinase, other polyanions have this property. Of rele-
vance to this discussion, there is at least one report concerns distribution of light chain. NHS anti-DNA are
overwhelming k, whereas SLE anti-DNA show levels ofindicating that, like other polyanions, DNA may activate
the kinase (Hovanessian and Galabru, 1987). It is possi- k and l similar to the overall serum content (Robertson et
al., 1992). The pattern of heavy and light chain utilizationble, therefore, that depending on the base composition
and pattern of methylation, bacterial DNA, like certain suggests that antibodies to bacterial DNA in NHS are
restricted and, as reflected in their heavy chain isotype,viral RNA, may display the appropriate structure to acti-
vate this enzyme. similar to the response to a bacterial carbohydrate in
their T independence. In contrast, the response to DNA
in SLE resembles that of a protein in isotype distribution
Induction of Antibodies by Bacterial DNA and appears T cell dependent.
The triggering of innate immunity by bacterial DNA is Immunization experiments directly comparing mam-
an intriguing possibility, although there is little evidence malian and bacterial DNA fully support the conclusion
at present to support this mechanism during infection. that bacterial DNA is immunogenic. When administered
Compelling data indicate, however, that bacterial DNA to mice as complexes with the carrier methylated bovine
can induce specific antibody responses in normal hu- serum albumin in complete Freund’s adjuvant, DNA from
mans, thereby refuting the dogma that antibody re- several bacterial species effectively induce antibody re-
sponses to DNA are exclusive to systemic lupus erythe- sponses. In ds form, DNA from E. coli can induce anti-
matosus (SLE). SLE is a prototypical autoimmune bodies that bind to bacterial dsDNA antigen without
disease characterized by multisystem involvement in cross-reactivity with mammalian dsDNA; in this pattern
association with antibodies to DNA (Emlen et al., 1986; of reactivity, these induced antibodies resemble anti-
Mackworth-Young and Schwartz, 1988). These antibod- bodies that occur spontaneously in normal humans (Gil-
ies have been considered essentially diagnostic of SLE keson et al., 1989a, 1989b, 1991). The enhanced immu-
and bind primarily to conformational determinants on nogenicity of bacterial DNA most likely results from its
both ssDNA and dsDNA (Pisetsky, 1992). content of CpG motifs.
To determine whether anti-DNA can bind sequences Until these studies, DNA had been considered to be
as well as conformations, the binding of sera to a panel uniformly nonimmunogenic by virtue of its conserved
of naturally occurring bacterial and mammalian DNA backbonedeterminants; these determinants arepresent
was analyzed. Although the behavior of these DNA was on all DNA, both foreign and self, and should be subject
similar with SLE sera (indicating binding to conserved to tolerance. In SLE, however, anti-DNA, although re-
conformational determinants), their interaction with con- acting with the conserved backbone, has features of
trol normal human sera (NHS) unexpectedly showed DNA antigen drive, such as clonal expression and vari-
marked differences. Thus, normal sera showed signifi- able region somatic mutations, including arginine resi-
cant binding to DNA from two bacteria, Micrococcus dues in CDR3 of the heavy chain (Diamond et al., 1992;
lysodeikticus and Staphylococcus epidermidis. The an- Radic and Weigert, 1994). These findings suggest either
tibodies in NHS were IgG and were present at levels that patients with SLE have a unique capacity to respond
equivalent to SLE. Importantly, NHS showed minimal to a nonimmunogenic molecule or that an antigen other
reactivity to other bacterial DNA and as well as mamma- than self-DNA drives this response.
lian DNA (Karounos et al., 1988). The anti-DNA antibod- Recent studies using bacterial DNA immunization as
ies in NHS were missed in previous studies because a model provide a new perspective on this central ques-
of a failure to survey an adequate number of DNA for tion in thepathogenesis of SLE. Thus,as shown recently,
antigenicity. preautoimmune New Zealand black/New Zealand white
Since DNA from only a few microorganisms have been (NZB/NZW) mice administered bacterial DNA as com-
characterized serologically, there are no rules as yet for plexes in adjuvant produce cross-reactive autoantibod-
predicting antigenicity. Of the limited number of DNA ies under conditions in which normal animals produce
studied thus far, DNA from common gram-negative bac- antibodies binding specifically to the immunizing anti-
teria (e.g., Escherichia coli) is not antigenic, while the gen. The induced anti-DNA in NZB/NZW mice bind both
bacterial and mammalian DNA, indicating recognitiontwo most antigenic DNA come from gram-positive skin
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of the conserved backbone, and resemble SLE autoanti- presence of interferon-g and IL-12. Furthermore, immu-
nostimulatory motifs may be critical to induction of im-bodies in their binding to synthetic polynucleotides. It is
important to note, therefore, that immunization of these munity by this approach, since the magnitude of re-
sponses induced by different vectors appears relatedautoimmune mice with calf thymus dsDNA under the
same conditions fails to induce a response, although to the content of these sequences (Raz et al., 1994,
1996; Mor et al., 1995; Sato et al., 1996).the animals can produce antibodies to this DNA either
spontaneously or following immunization with bacterial Since plasmid constructs have immunostimulatory
sequences, they can theoretically provoke adverse ef-DNA (Gilkeson et al., 1995).
Together, these studies suggest a potential mecha- fects in the immunized host. These effects include local
inflammation; a shift of the Th1/Th2 cell balance andnism for the induction of anti-DNA in SLE and explain
how bacterial DNA can drive a specific autoantibody consequent alteration in defense against infection; and
induction of anti-DNA. If the induced anti-DNA antibod-response. Thus, under conditions in which it drives anti-
bodies to sequential determinants in normal animals, ies resemble antibodies in normal humans, the effects
are likely minor; such IgG2 antibodies do not fix comple-bacterial DNA in genetically susceptible individuals may
drive autoantibodies to conserved, conformational de- ment and would be blind to host DNA. In an individual
genetically predisposed to autoimmunity, however, theterminants. The propensity of susceptible individuals to
produce cross-reactive autoantibodies may result from immunizing DNA could induce anti-DNA, which, like SLE
autoantibodies, cross-react with host DNA and causea B cell repertoire skewed to autoreactivity by tolerance
defects. Because of the content of precursors that tissue injury. The consequences of such induced re-
sponses (e.g., immune complex disease) could be exac-would be deleted or anergized in normal individuals,
the susceptible individual has the capacity to produce erbated by cytokine effects provoked by the plasmid.
While the occurrence of these untoward events is specu-cross-reactive autoantibodies when stimulated by for-
eign antigen (Gilkeson et al., 1993). In a sense, however, lative at present, the capacity of plasmids for inducing
systemic inflammation and autoantibody productionbacterial DNA is both a foreign and self-antigen because
of its sequence (foreign) and conformation (self). must be observed with caution as this strategy for immu-
nization is tested in man.A corollary of this notion is that immunomodulatory
effects of bacterial DNA enhance B cell responses to The success of DNA immunization has been remark-
able since this approach involves seemingly formidableDNA antigen, whether the determinant is a conserved
conformation or a nonconserved sequence. Indeed, the biological obstacles: passage of a large, highly charged
molecule into the cell interior; resistance of the constructfailure of calf thymus tail dsDNA to induce autoantibod-
ies in preautoimmune NZB/NZW mice suggests that, to intracellular enzymatic attack; long-term gene ex-
pression; and resistance of transduced cells to attackwithout the mitogenic effect of immunostimulatory CpG
motifs, DNA does not effectively trigger B cells even with by antibody or cytotoxic T cells. Given the effectiveness
of DNA immunization, it is reasonable to questionan appropriate immunoglobulin receptor. Interestingly,
some DNA bound in immune complexes in SLE sera whether this phenomenon has a counterpart in normal
immunity and whether systems have in fact evolved tohave bacterial sequences, suggesting that foreign DNA
does play an in vivo role in this disease (Terada et al., take up foreign DNA during infection and perhaps even
to allow expression (Pisetsky, 1993; Raz et al., 1994).1991).
This possibility seems more plausible with viral than
bacterial DNA, because the presence of appropriate
Implications for the Therapeutic Use of DNA DNA-regulatory elements on the viral DNA should allow
While bacterial DNA may have limited access to the cellular expression.
immune system during infection, the therapeutic use of Antisense is another new approach to disease therapy
nucleic acids will expose humans to high concentrations that entails in vivo administration of free nucleic acids.
of free DNA, some of which will have sequences from Antisense compounds are small oligonucleotides that
bacteria. Among these uses, DNA immunization has at- can bind to regions of mRNA and allow highly specific
tracted the most attention because of its enormous po- reduction of their protein products. These compounds
tential for developing new vaccines. In this approach, a form duplexes that block transcription orpromote diges-
plasmid encoding a foreign protein is administered to tion by RNase H. Although phosphodiesters can exert
a host. By an unknown mechanism, this plasmid is taken antisense effects, most current efforts involve nucleic
up into cells and expressed, leading to the induction of acid derivatives that have chemical modifications to re-
both cellular and humoral immunity (Tang et al., 1992; sist nuclease digestion or promote penetration into cells
Ulmer et al., 1993; Pardoll and Beckerleg, 1995). (Stein and Cheng, 1993; Wagner, 1994).
Since plasmids used for immunization are propagated Among derivatives explored for antisense use, phos-
in bacteria, they necessarily bear bacterial DNA se- phorothioates have achieved the most widespread use.
quences (including CpG motifs) as well as the bacterial Phosphorothioates have a sulfur substitution for one of
pattern of base methylation. As such, these plasmids the nonbridging oxygens in the phosphodiester back-
can induce cytokine production in humans as well as bone. This substitution influences the physical proper-
mice; in mice, these plasmids may also activate B cells ties of DNA, including altering the melting temperature
and serve as adjuvants. The induction of cytokines may as well as increasing resistance to nucleolytic cleavage.
influence the nature of the T cell response, since, for Phosphorothioates used for therapy are usually short
most DNA immunizations, the predominant response is (<30 bases) and do not contain methylated cytosines
(Stein and Cheng, 1993).T helper type 1 (Th1), a distribution consistent with the
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Inducers of interferon and host resistance. II. Multistranded syn-As shown both in vitro and in vivo, phosphorothioate
thetic polynucleotide complexes. Proc. Natl. Acad. Sci. USA 58,oligonucleotides have powerful immunological activi-
1004–1010.ties, some of which mimic those of bacterial DNA. Thus,
Fredriksen, K., Skogsholm, A., Flaegstad, T., Traavik, T., and Rekvig,depending on sequence, phosphorothioates are mito-
O.P. (1993). Antibodies to dsDNA are produced during primary BKgenic both for murine and human B cells; in vivo, phos-
virus infection in man, indicating that anti-dsDNA antibodies may be
phorothioates can induce splenomegaly and polyclonal related to virus replication in vivo. Scand. J. Immunol. 38, 401–406.
B cell activation in mice. While phosphorothioates with
Gilkeson, G.S., Grudier, J.P., and Pisetsky, D.S. (1989a). The anti-
CpG motifs are active, B cell mitogenesis does not re- body response of normal mice to immunization with single-stranded
quire these sequences. In general, phosphorothioates DNA of various species origin. Clin. Immunol. Immunopathol. 51,
are more active than the corresponding phosphodies- 362–371.
ters of the same sequence (Branda et al., 1993; Pisetsky Gilkeson, G.S., Grudier, J.P., Karounos, D.G., and Pisetsky, D.S.
and Reich, 1993, 1994; Krieg et al., 1995; Zhao et al., (1989b). Induction of anti-dsDNA antibodies in normal mice by im-
munization with bacterial DNA. J. Immunol. 142, 1482–1486.1996). These considerations suggest that the sulfur sub-
stitution leads to a backbone structure that is immuno- Gilkeson, G.S., Pritchard, A.J., and Pisetsky, D.S. (1991). Specificity
of anti-DNA antibodies induced in normal mice by immunizationlogically active even in the absence of CpG motifs that
with bacterial DNA. Clin. Immunol. Immunopathol. 59, 288–300.are optimally stimulatory as phosphodiesters. Thus, im-
Gilkeson, G.S., Bloom, D.D., Pisetsky, D.S., and Clarke, S.H. (1993).mune effects of phosphorothioates may occur even with
Molecular characterization of anti-DNA antibodies induced in normalsequences that are not “foreign” as defined by their
mice by immunization with bacterial DNA: differences from sponta-content in the mammalian genome.
neous anti-DNA in the content and location of VH CDR3 arginines.
J. Immunol. 151, 1353–1364.
Conclusion Gilkeson, G.S., Pippen, A.M.M., and Pisetsky, D.S. (1995). Induction
of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/DNA is a molecule whose structural microheterogeneity
NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95,encodes enormous information. Most of the information
1398–1402.is complex as it conveys instructions for the precise
Halpern, M.D., Kurlander, R.J., and Pisetsky, D.S. (1996). Bacterialstructure and regulation of thousands of genes. Some
DNA induces murine interferon-g production by stimulation of in-of this information is simple, however, and provides in
terleukin-12 and tumor necrosis factor-a. Cell. Immunol. 167, 72–78.a direct and binary code data for the immune system
Hefeneider, S.H., McCoy, S.L., Morton, J.I., Bakke, A.C., Cornell,to make the self–nonself discrimination. The extent to
K.A., Brown, L.E., and Bennett, R.M. (1992). DNA binding to mousewhich the immune system uses this information is at
cells is mediated by cell-surface molecules: the role of these DNA-
present unknown, but the coming years should be intri- binding molecules as target antigens in murine lupus. Lupus 1,
guing as evidence is gathered toassess this unexpected 167–173.
potential of DNA. Hergersberg, M. (1991). Biological aspects of cytosine methylation
in eukaryotic cells. Experientia 47, 1171–1185.
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